Cargando…
Timing of Treatment with the Flavonoid 7,8-DHF Critically Impacts on Its Effects on Learning and Memory in the Ts65Dn Mouse
No therapies currently exist for intellectual disability in Down syndrome (DS). In view of its similarities with DS, including learning and memory (L&M) defects, the Ts65Dn mouse model of DS is widely used for the design of therapy. 7,8-dihydroxyflavone (7,8-DHF), a flavonoid that targets the tr...
Autores principales: | Giacomini, Andrea, Stagni, Fiorenza, Emili, Marco, Uguagliati, Beatrice, Rimondini, Roberto, Bartesaghi, Renata, Guidi, Sandra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6617346/ https://www.ncbi.nlm.nih.gov/pubmed/31174258 http://dx.doi.org/10.3390/antiox8060163 |
Ejemplares similares
-
The flavonoid 7,8-DHF fosters prenatal brain proliferation potency in a mouse model of Down syndrome
por: Stagni, Fiorenza, et al.
Publicado: (2021) -
Impaired Brain Mitochondrial Bioenergetics in the Ts65Dn Mouse Model of Down Syndrome Is Restored by Neonatal Treatment with the Polyphenol 7,8-Dihydroxyflavone
por: Valenti, Daniela, et al.
Publicado: (2021) -
Inhibition of APP gamma-secretase restores Sonic Hedgehog signaling and neurogenesis in the Ts65Dn mouse model of Down syndrome
por: Giacomini, Andrea, et al.
Publicado: (2015) -
Long-term effect of neonatal inhibition of APP gamma-secretase on hippocampal development in the Ts65Dn mouse model of Down syndrome
por: Stagni, Fiorenza, et al.
Publicado: (2017) -
Pharmacotherapy with Fluoxetine Restores Functional Connectivity from the Dentate Gyrus to Field CA3 in the Ts65Dn Mouse Model of Down Syndrome
por: Stagni, Fiorenza, et al.
Publicado: (2013)